HER2 Neu Negative Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-04-25
Clinical Trial Update: Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer [Phase 1]
Phase 1 trial investigating eribulin mesylate and everolimus in triple-negative metastatic breast cancer has completed with results posted.